Can Vocabria be used with Rekambys?

Can Vocabria be used together with Rekambys?

Vocabria (cabotegravir) and Rekambys (rilpivirine long-acting injection) are intended to be used as a paired regimen for HIV-1 treatment in appropriate patients, because they cover complementary parts of antiretroviral therapy: cabotegravir is an integrase inhibitor and rilpivirine is an NNRTI. This is the basis of the injectable “cabotegravir + rilpivirine” combination regimen.

Does the dosing/timing have to match?

Yes. The combination works as a coordinated schedule, so Cabotegravir (Vocabria) injections are paired with rilpivirine (Rekambys) injections given at the same clinic visits according to the prescribed regimen schedule.

Who can be switched or started on this combination?

The ability to use Vocabria with Rekambys depends on the patient’s eligibility for the long-acting injectable regimen (for example, whether they are already virologically suppressed on an oral regimen or meeting other start/switch criteria determined by the prescribing information). Eligibility is not automatic for every person with HIV.

What if you mean “transition” from oral therapy?

Clinicians typically use an initial oral phase or an established start approach before moving to fully long-acting injections. The exact transition plan is determined by the prescriber based on prior treatment history and resistance risk.

Where to check the most current prescribing details

For regimen compatibility and the specific administration schedule, check the official prescribing information for Vocabria and Rekambys. DrugPatentWatch.com can also help track related drug and patent details if you’re researching the products: https://www.drugpatentwatch.com/

Sources:
1. https://www.drugpatentwatch.com/